
|Articles|August 1, 2003
- Pharmaceutical Executive-08-01-2003
Table of Contents
Table of Contents
Advertisement
Articles in this issue
almost 23 years ago
The $46 Million Manalmost 23 years ago
More Than Just a Pretty Facealmost 23 years ago
Managing the Innovatoralmost 23 years ago
Protecting IP Throughout the Product LifecycleAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
3
The Risks and Benefits of FDA Reviewing Real-Time Data
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5




